This hottest twist from the Lykos Therapeutics saga threatens An important overhaul of the corporation’s technique and route, with Musk ally and billionaire investor Antonio Gracias showing up to want to consider the corporation back again toward its nonprofit drug progress roots and a more Doblinite philosophy.Wonderful although not for that fai